BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 35060480)

  • 1. The mitochondrial profile in women with polycystic ovary syndrome: impact of exercise.
    Malamouli M; Levinger I; McAinch AJ; Trewin AJ; Rodgers RJ; Moreno-Asso A
    J Mol Endocrinol; 2022 Mar; 68(3):R11-R23. PubMed ID: 35060480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Androgens in polycystic ovary syndrome: the role of exercise and diet.
    Giallauria F; Palomba S; Vigorito C; Tafuri MG; Colao A; Lombardi G; Orio F
    Semin Reprod Med; 2009 Jul; 27(4):306-15. PubMed ID: 19530064
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-intensity training elicits greater improvements in cardio-metabolic and reproductive outcomes than moderate-intensity training in women with polycystic ovary syndrome: a randomized clinical trial.
    Patten RK; McIlvenna LC; Levinger I; Garnham AP; Shorakae S; Parker AG; McAinch AJ; Rodgers RJ; Hiam D; Moreno-Asso A; Stepto NK
    Hum Reprod; 2022 May; 37(5):1018-1029. PubMed ID: 35325125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peri-muscular adipose tissue may play a unique role in determining insulin sensitivity/resistance in women with polycystic ovary syndrome.
    Morrison SA; Goss AM; Azziz R; Raju DA; Gower BA
    Hum Reprod; 2017 Jan; 32(1):185-192. PubMed ID: 27827322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effectiveness of high intensity intermittent training on metabolic, reproductive and mental health in women with polycystic ovary syndrome: study protocol for the iHIT- randomised controlled trial.
    Hiam D; Patten R; Gibson-Helm M; Moreno-Asso A; McIlvenna L; Levinger I; Harrison C; Moran LJ; Joham A; Parker A; Shorakae S; Simar D; Stepto N
    Trials; 2019 Apr; 20(1):221. PubMed ID: 30992038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of exercise training on insulin sensitivity, mitochondria and computed tomography muscle attenuation in overweight women with and without polycystic ovary syndrome.
    Hutchison SK; Teede HJ; Rachoń D; Harrison CL; Strauss BJ; Stepto NK
    Diabetologia; 2012 May; 55(5):1424-34. PubMed ID: 22246378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adipose Tissue Dysfunction in Polycystic Ovary Syndrome.
    Bril F; Ezeh U; Amiri M; Hatoum S; Pace L; Chen YH; Bertrand F; Gower B; Azziz R
    J Clin Endocrinol Metab; 2023 Dec; 109(1):10-24. PubMed ID: 37329216
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations of Vitamin D with Inter- and Intra-Muscular Adipose Tissue and Insulin Resistance in Women with and without Polycystic Ovary Syndrome.
    Scott D; Joham A; Teede H; Gibson-Helm M; Harrison C; Cassar S; Hutchison S; Ebeling PR; Stepto N; de Courten B
    Nutrients; 2016 Nov; 8(12):. PubMed ID: 27916865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low-frequency electro-acupuncture and physical exercise improve metabolic disturbances and modulate gene expression in adipose tissue in rats with dihydrotestosterone-induced polycystic ovary syndrome.
    Mannerås L; Jonsdottir IH; Holmäng A; Lönn M; Stener-Victorin E
    Endocrinology; 2008 Jul; 149(7):3559-68. PubMed ID: 18388196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adipose tissue dysfunction in polycystic ovary syndrome.
    Villa J; Pratley RE
    Curr Diab Rep; 2011 Jun; 11(3):179-84. PubMed ID: 21424395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heat therapy improves glucose tolerance and adipose tissue insulin signaling in polycystic ovary syndrome.
    Ely BR; Clayton ZS; McCurdy CE; Pfeiffer J; Needham KW; Comrada LN; Minson CT
    Am J Physiol Endocrinol Metab; 2019 Jul; 317(1):E172-E182. PubMed ID: 31136202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?
    Corbould A
    Panminerva Med; 2008 Dec; 50(4):279-94. PubMed ID: 19078869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial dysfunction: An emerging link in the pathophysiology of polycystic ovary syndrome.
    Shukla P; Mukherjee S
    Mitochondrion; 2020 May; 52():24-39. PubMed ID: 32081727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperandrogenism and insulin resistance-induced fetal loss: evidence for placental mitochondrial abnormalities and elevated reactive oxygen species production in pregnant rats that mimic the clinical features of polycystic ovary syndrome.
    Zhang Y; Zhao W; Xu H; Hu M; Guo X; Jia W; Liu G; Li J; Cui P; Lager S; Sferruzzi-Perri AN; Li W; Wu XK; Han Y; Brännström M; Shao LR; Billig H
    J Physiol; 2019 Aug; 597(15):3927-3950. PubMed ID: 31206177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential effects of aerobic exercise on the expression of perilipin 3 in the adipose tissue of women with polycystic ovary syndrome: a pilot study.
    Covington JD; Bajpeyi S; Moro C; Tchoukalova YD; Ebenezer PJ; Burk DH; Ravussin E; Redman LM
    Eur J Endocrinol; 2015 Jan; 172(1):47-58. PubMed ID: 25342854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-cell autonomous mechanisms control mitochondrial gene dysregulation in polycystic ovary syndrome.
    Moreno-Asso A; Altıntaş A; McIlvenna LC; Patten RK; Botella J; McAinch AJ; Rodgers RJ; Barrès R; Stepto NK
    J Mol Endocrinol; 2021 Dec; 68(1):63-76. PubMed ID: 34752415
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies.
    Sanchez-Garrido MA; Tena-Sempere M
    Mol Metab; 2020 May; 35():100937. PubMed ID: 32244180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Declining muscle NAD
    Aflatounian A; Paris VR; Richani D; Edwards MC; Cochran BJ; Ledger WL; Gilchrist RB; Bertoldo MJ; Wu LE; Walters KA
    Mol Metab; 2022 Nov; 65():101583. PubMed ID: 36096453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
    Goodman NF; Cobin RH; Futterweit W; Glueck JS; Legro RS; Carmina E; ; ;
    Endocr Pract; 2015 Dec; 21(12):1415-26. PubMed ID: 26642102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progressive resistance training in polycystic ovary syndrome: can pumping iron improve clinical outcomes?
    Cheema BS; Vizza L; Swaraj S
    Sports Med; 2014 Sep; 44(9):1197-207. PubMed ID: 24872311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.